Dexcom (DXCM) Receivables - Net (2010 - 2026)

Dexcom (DXCM) has 17 years of Receivables - Net data on file, last reported at $1.1 billion in Q1 2026.

• Receivables - Net for Q1 2026 came in at $1.1 billion, down 5.77% year-over-year; the trailing twelve-month figure through Mar 2026 was $1.1 billion (down 5.77% YoY), and the FY2025 annual result was $1.2 billion, up 20.92% from the prior year.
• Receivables - Net retreated to $1.1 billion in Q1 2026 per DXCM's latest filing, from $1.2 billion in the prior quarter.
• Over five years, Receivables - Net peaked at $1.3 billion in Q2 2025 and troughed at $544.5 million in Q1 2022.
• A 5-year average of $904.7 million and a median of $973.9 million in 2023 frame the typical range for Receivables - Net.
• The sharpest annual moves came in 2024 and 2026: Receivables - Net surged 53.67% in 2024, then retreated 5.77% in 2026.
• A 5-year view of Receivables - Net shows it stood at $713.3 million in 2022, then surged by 36.53% to $973.9 million in 2023, then climbed by 3.27% to $1.0 billion in 2024, then rose by 20.92% to $1.2 billion in 2025, then retreated by 10.48% to $1.1 billion in 2026.
• Business Quant data shows DXCM's Receivables - Net at $1.1 billion in Q1 2026, $1.2 billion in Q4 2025, and $1.1 billion in Q3 2025.